Vinaora Nivo SliderVinaora Nivo SliderVinaora Nivo SliderVinaora Nivo Slider

Cardno ChemRisk Publications

Display # 
1 Biegel, L., M.A. Harris, D. Davis, R. Rosengren, L. Safe, and S. Safe. 1989. 2,2',4,4',5,5'-hexachlorobiphenyl as a 2,3,7,8-tetrachlorodibenzo-p-dioxin antagonist in C57BL/6J mice. Toxicol Appl Pharmacol. 97:561-71.
2 Birnbaum, L.S., L.A. Couture, and M.R. Elwell. 1989. Subchronic effects of exposure to Octachlorodibenzo-p-dioxin (OCDD). Chemosphere. 18(1-6):389-390.
3 Couture, L.A., M.A. Harris, and L.S. Birnbaum. 1989. Developmental toxicity of 2,3,4,7,8-pentachlorodibenzofuran (4-PeCDF) in the Fischer 344 rat. Fund Appl Toxicol. 12:358-66.
4 Finley, B.L. 1989. Using risk assessment requirements to design cost-effective remedial investigations. HazMat West Proc.
5 Harris, M.A., J. Piskorska-Pliszczynska, T. Zacharewski, M. Romkes, and S. Safe. 1989. Structure-dependent induction of aryl hydrocarbon hydroxylase in human breast cancer cell lines and characterization of the Ah receptor. Cancer Res. 49:4531-5.
6 Harris, M.A., T. Zacharewski, B. Astroff, and S. Safe. 1989. Partial antagonism of 2,3,7,8-tetrachlorodibenzo-p-dioxin mediated induction of aryl hydrocarbon hydroxylase by 6-methyl-1,3,8-trichlorodibenzofuran: mechanistic studies. Mol Pharmacol. 35:729-35.
7 Harris, M.A., T. Zacharewski, B. Astroff, C. Kamps, and S. Safe. 1989. Characterization of 6-methyl-1,3,8-trichlorodibenzofuran (MCDF) as a 2,3,7,8-TCDD antagonist in male rats: induction of monooxygenases. Chemosphere. 19:769-72.
8 Leung, H.W., D.J. Paustenbach, and M.E. Andersen. 1989. A physiologically-based pharmacokinetics model for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chemosphere. 18:659-64.
9 Leung, H.W., F.J. Murray, and D.J. Paustenbach. 1989. Documentation for an occupational exposure limit for 2,3,7,8-tetrachlorodibenzo-p-dioxin. Chemosphere. 18(1-6):1115-22.
10 Paustenbach, D.J. 1989. Health risk assessments: Opportunities and pitfalls. Columbia J Environ Law. 41(2):379-410.
11 Paustenbach, D.J. 1989. Important recent advances in the practice of health risk assessment: Implications for the 1990s. Regul Toxicol Pharmacol. 10:204-43.
12 Paustenbach, D.J. 1989. Toxic chemicals and health risk assessments in regulation and litigation. The Record of the Association of the Bar of The City of New York. Summary of oral paper. 44:406-9.
13 Paustenbach, D.J. and R. Keenan. 1989. Health risk assessment in the 1990s. Hazmat World. 2(11):44-56.
14 Safe, S., G. Mason, T. Sawyer, T. Zacharewski, M.A. Harris, C. Yao, B. Keys, K. Farrell, M. Holcomb, D. Davis, L. Safe, J. Piskorska-Pliszcyzynska, B. Leece, M. Denomme, O. Hutzinger, H. Thoma, B. Chittim, and J. Madge. 1989. Development and validation of in vitro induction assays for toxic halogenated aromatic mixtures: A review. Toxicol Ind Health 5(5):757-75.
15 Safe, S., T. Zacharewski, L. Safe, M.A. Harris, C. Yao, and M. Holcomb. 1989. Validation of the AHH induction bioassay for the determination of 2,3,7,8-TCDD toxic equivalents. Chemosphere. 18(1-6):941-6.
16 Zacharewski, T., M.A. Harris, and S. Safe. 1989. Induction of cytochrome P450-dependent monooxygenase activities in rat hepatoma H-4-IIE cells in culture by 2,3,7,8-tetrachlorodibenzo-p-dioxin and related compounds: Mechanistic studies using radiolabeled congeners. Arch Biochem Biophys. 272(2):344-55.
17 Zacharewski, T., M.A. Harris, S. Safe, H. Thoma, G. Hauschulz, E. Knorr, and O. Hutzinger. 1989. Application of the in vitro AHH induction bioassay for determining 2,3,7,8-TCDD equivalents: pyrolyzed flame retardant mixtures. Chemosphere. 18(1-6):383-7.

Search all Publications by author's last name, title or keyword